Company Analysis

Polyrizon Ltd. (PLRZ)

Nasdaq: PLRZ · Surgical & Medical Instruments & Apparatus · filing with the SEC since 2022
Grade6.3
◀ Past 7.2● Present 6.8▶ Future 4.7
7 est.

Who runs Polyrizon Ltd.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Izraeli Tomer
Chief Executive Officer. First filing Mar 2026, latest Apr 1, 2026, 2 filings in all.
Officers reporting now
4
of 9 people with a filing in the last fifteen months
Directors reporting now
5
9 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Izraeli TomerChief Executive OfficerMar 2026Apr 1, 20262 · $0.00
Turgeman TidharChief Technology OfficerMar 2026Mar 31, 20261 · $0.00
Benyosef NirChief Financial OfficerMar 2026Mar 18, 2026none
Ron Eyal SChief Science OfficerMar 2026Mar 18, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Adler OzdirectorMar 2026Apr 1, 20261 · $0.00
Carmel LirondirectorMar 2026Apr 1, 20262 · $0.00
Itzhaik AsafdirectorMar 2026Mar 18, 2026none
Sidi LiatdirectorMar 2026Mar 18, 2026none
Vinokur Yehonatan ZalmandirectorMar 2026Mar 18, 2026none

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton PLRZ · research, not advice